Related Experiment Video
Updated: Dec 14, 2025

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
Published on: May 27, 2015
Mastocytosis: One Word for Different Diseases
Marianna Criscuolo1, Luana Fianchi2, Alessio M E Maraglino3
1Dipartimento di Scienze Radiologiche Radioterapiche ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. marianna.criscuolo@policlinicogemelli.it.
Mastocytosis is a neoplastic disease involving mast cells, requiring a high index of suspicion for diagnosis. Management and prognosis vary significantly based on disease form, from cutaneous to aggressive systemic types.
Area of Science:
- Hematology
- Oncology
- Dermatology
Background:
- Mastocytosis is a neoplastic proliferation of mast cells infiltrating tissues.
- Diagnosis can be challenging due to diverse clinical presentations.
- Classified by WHO into localized (cutaneous) and systemic forms with varying aggressiveness.
Purpose of the Study:
- To outline the diagnostic work-up for mastocytosis in adult patients.
- To describe the range of treatment options available.
- To highlight the prognostic variability of the disease.
Main Methods:
- Bone marrow evaluation with molecular analyses.
- Skeletal X-ray and abdominal imaging.
- Allergologic and dermatologic assessments.
Main Results:
- Diagnostic work-up includes bone marrow, skeletal, abdominal, and specialist evaluations.
- Treatment ranges from symptomatic drugs (antihistamines, steroids) and UV irradiation to cytoreductive therapy.
- Prognosis spans from normal life expectancy in cutaneous mastocytosis to poor survival in mast cell leukemia.
Conclusions:
- Mastocytosis management necessitates a multidisciplinary approach.
- Tailored treatment strategies are crucial based on disease subtype and aggressiveness.
- Early and accurate diagnosis significantly impacts patient outcomes and prognosis.
More Related Videos
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Differentiation of Common Myeloid Progenitor Cells
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Abnormal Proliferation
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...

